BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/12/2026 9:50:50 AM | Browse: 0 | Download: 0
 |
Received |
|
2025-10-10 01:02 |
|
Peer-Review Started |
|
2025-10-10 01:02 |
|
First Decision by Editorial Office Director |
|
2025-11-05 09:10 |
|
Return for Revision |
|
2025-11-05 09:10 |
|
Revised |
|
2025-11-16 16:39 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-12-23 02:39 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-12-23 07:33 |
|
Articles in Press |
|
2025-12-23 07:33 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-01-04 03:46 |
|
Publish the Manuscript Online |
|
2026-01-12 09:50 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
The triglyceride-glucose index shows promise as a novel prognostic marker for advanced hepatocellular carcinoma
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Tao Xu, Xu Qi, Fei-Yu Zhao and Nian-Song Qian |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Fei-Yu Zhao, PhD, Department of Radiation Oncology, The Fifth Medical Center of Chinese People’s Liberation Army General Hospital, No. 8 East Main Street, Fengtai District, Beijing 100071, China. 1029279130@qq.com |
| Key Words |
Triglyceride-glucose index; Prognostic marker; Advanced hepatocellular carcinoma; Camrelizumab; Lenvatinib |
| Core Tip |
This commentary highlights triglyceride-glucose (TyG) index as a prognostic marker for hepatitis B virus-related advanced hepatocellular carcinoma on camrelizumab-lenvatinib. Low TyG (< 1.58) boosts survival, it’s an independent predictor, with limitations needing multicenter studies. |
| Publish Date |
2026-01-12 09:50 |
| Citation |
Xu T, Qi X, Zhao FY, Qian NS. The triglyceride-glucose index shows promise as a novel prognostic marker for advanced hepatocellular carcinoma. World J Gastroenterol 2026; 32(2): 115178 |
| URL |
https://www.wjgnet.com/1007-9327/full/v32/i2/115178.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v32.i2.115178 |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
